The subsequent huge battle over abortion has begun
[ In April 2023, Trump-appointed Decide Matthew Kaksmarick of the Northern District of Texas issued a preliminary ruling on the FDA case invalidating the company's approval of mifepristone. The choice prompted a shock wave far past the reproductive-rights world, because it had main implications for the whole pharmaceutical trade in addition to the FDA; The … Read more